Thompson Lester D R, Bouffard John-Paul, Sandberg Glenn D, Mena Hernando
Department of Endocrine and Otorhinolaryngic-Head & Neck Pathology, Armed Forces Institute of Pathology, Washington, DC 20306, USA.
Mod Pathol. 2003 Mar;16(3):236-45. doi: 10.1097/01.MP.0000056631.15739.1B.
"Primary" ear and temporal bone meningiomas are tumors that are frequently misdiagnosed and unrecognized, resulting in inappropriate clinical management. To date, a large clinicopathologic study of meningiomas in this anatomic site has not been reported. Thirty-six cases of ear and temporal bone meningiomas diagnosed between 1970 and 1996 were retrieved from our files. Histologic features were reviewed, immunohistochemical analysis was performed (n = 19), and patient follow-up was obtained (n = 35). The patients included 24 females and 12 males, aged 10-80 years (mean, 49.6 years), with female patients presenting at an older age (mean, 52.0 years) than male patients (mean, 44.8 years). Patients presented clinically with hearing changes (n = 20), otitis (n = 7), pain (n = 5), and/or dizziness/vertigo (n = 3). Symptoms were present for an average of 24.6 months. The tumors affected the middle ear (n = 25), external auditory canal (n = 4), or a combination of temporal bone and middle ear (n = 7). The tumors ranged in size from 0.5 to 4.5 cm in greatest dimension (mean, 1.2 cm). Radiographic studies demonstrated a central nervous system connection in 2 patients. Histologically, the tumors demonstrated features similar to those of intracranial meningiomas, including meningothelial (n = 33), psammomatous (n = 2), and atypical (n = 1). An associated cholesteatoma was identified in 9 cases. Immunohistochemical studies confirmed the diagnosis of meningioma with positive reactions for epithelial membrane antigen (79%) and vimentin (100%). The differential diagnosis includes paraganglioma, schwannoma, carcinoma, melanoma, and middle ear adenoma. Surgical excision was used in all patients. Ten patients developed a recurrence from 5 months to 2 years later. Five patients died with recurrent disease (mean, 3.5 years), and the remaining 30 patients were alive (n = 25, mean: 19.0 years) or had died (n = 5, mean: 9.5 years) of unrelated causes without evidence of disease. We conclude that extracranial ear and temporal bone meningiomas are rare tumors histologically similar to their intracranial counterparts. They behave as slow-growing neoplasms with a good overall prognosis (raw 5-y survival, 83%). Extent of surgical excision is probably the most important factor in determining outlook because recurrences develop in 28% of cases.
“原发性”耳及颞骨脑膜瘤是常被误诊和漏诊的肿瘤,导致临床处理不当。迄今为止,尚未见关于该解剖部位脑膜瘤的大型临床病理研究报道。从我们的档案中检索出1970年至1996年间诊断的36例耳及颞骨脑膜瘤病例。回顾了组织学特征,进行了免疫组化分析(n = 19),并获得了患者的随访结果(n = 35)。患者包括24名女性和12名男性,年龄10 - 80岁(平均49.6岁),女性患者就诊时年龄(平均52.0岁)大于男性患者(平均44.8岁)。患者临床症状表现为听力改变(n = 20)、中耳炎(n = 7)、疼痛(n = 5)和/或头晕/眩晕(n = 3)。症状平均持续24.6个月。肿瘤累及中耳(n = 25)、外耳道(n = 4)或颞骨和中耳联合受累(n = 7)。肿瘤最大径范围为0.5至4.5 cm(平均1.2 cm)。影像学检查显示2例患者存在与中枢神经系统的连接。组织学上,肿瘤表现出与颅内脑膜瘤相似的特征,包括脑膜上皮型(n = 33)、砂粒体型(n = 2)和非典型型(n = 1)。9例患者伴有胆脂瘤。免疫组化研究通过上皮膜抗原(79%)和波形蛋白(100%)阳性反应证实了脑膜瘤的诊断。鉴别诊断包括副神经节瘤、神经鞘瘤、癌、黑色素瘤和中耳腺瘤。所有患者均采用手术切除。10例患者在5个月至2年后复发。5例患者因复发疾病死亡(平均3.5年),其余30例患者存活(n = 25,平均19.0年)或死于(n = 5,平均9.5年)无关原因,无疾病证据。我们得出结论,颅外耳及颞骨脑膜瘤是罕见肿瘤,组织学上与其颅内对应物相似。它们表现为生长缓慢的肿瘤,总体预后良好(原始5年生存率,83%)。手术切除范围可能是决定预后的最重要因素,因为28%的病例会复发。